Hrmmm.. well,
It's a matter of conjecture of "priced in" on any approval.
i personally would consider $1 a share for a genuine medical approval for a USA based pharmaceutical product to be an incredibly cheap "priced in" share price.
I personal think that view is incorrect @vasilios
If you believe it is priced in already...you may as well sell now and buy the dips ahead?
600-billion (avg USA market) - https://www.statista.com/topics/1719/pharmaceutical-industry/
Pick Today's Price Range Low-High... Just for Fun, page-680
-
- There are more pages in this discussion • 653 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
-0.020(1.32%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.53 | $1.48 | $3.367M | 2.243M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 25858 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 35713 | 10 |
View Market Depth
| Last trade - 13.35pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |